Market revenue in 2023 | USD 1.0 million |
Market revenue in 2030 | USD 2.2 million |
Growth rate | 12.6% (CAGR from 2023 to 2030) |
Largest segment | Pure prp |
Fastest growing segment | Leukocyte Rich PRP |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pure PRP, Leukocyte Rich PRP |
Key market players worldwide | Johnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences |
Pure prp was the largest segment with a revenue share of 50% in 2023. Horizon Databook has segmented the Kuwait platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.
Kuwait is one of the fastest-growing countries in MENA due to its increasing exports and growing economy. With major advancements in its healthcare infrastructure, the country is addressing the growing prevalence of infectious, chronic, and lifestyle-associated diseases. Therefore, the rising prevalence of target diseases in the country is a major factor driving the PRP market.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account